316 related articles for article (PubMed ID: 17719654)
21. The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis.
Chen J; Xie L; Toyama S; Hünig T; Takahara S; Li XK; Zhong L
Int Immunopharmacol; 2011 May; 11(5):610-7. PubMed ID: 21163250
[TBL] [Abstract][Full Text] [Related]
22. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression.
Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G
Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480
[TBL] [Abstract][Full Text] [Related]
23. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.
De Vry CG; Prasad S; Komuves L; Lorenzana C; Parham C; Le T; Adda S; Hoffman J; Kahoud N; Garlapati R; Shyamsundar R; Mai K; Zhang J; Muchamuel T; Dajee M; Schryver B; McEvoy LM; Ehrhardt RO
Gut; 2007 Apr; 56(4):524-33. PubMed ID: 16950831
[TBL] [Abstract][Full Text] [Related]
24. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.
Gonzalez-Rey E; Anderson P; González MA; Rico L; Büscher D; Delgado M
Gut; 2009 Jul; 58(7):929-39. PubMed ID: 19136511
[TBL] [Abstract][Full Text] [Related]
25. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
26. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
27. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes.
Ilan Y; Weksler-Zangen S; Ben-Horin S; Diment J; Sauter B; Rabbani E; Engelhardt D; Chowdhury NR; Chowdhury JR; Goldin E
Am J Gastroenterol; 2000 Apr; 95(4):966-73. PubMed ID: 10763946
[TBL] [Abstract][Full Text] [Related]
28. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
29. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model.
Trop S; Samsonov D; Gotsman I; Alper R; Diment J; Ilan Y
Hepatology; 1999 Mar; 29(3):746-55. PubMed ID: 10051476
[TBL] [Abstract][Full Text] [Related]
30. Orally administered apple procyanidins protect against experimental inflammatory bowel disease in mice.
Yoshioka Y; Akiyama H; Nakano M; Shoji T; Kanda T; Ohtake Y; Takita T; Matsuda R; Maitani T
Int Immunopharmacol; 2008 Dec; 8(13-14):1802-7. PubMed ID: 18824249
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic action of ghrelin in a mouse model of colitis.
Gonzalez-Rey E; Chorny A; Delgado M
Gastroenterology; 2006 May; 130(6):1707-20. PubMed ID: 16697735
[TBL] [Abstract][Full Text] [Related]
33. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
34. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
35. Dietary lactoferrin does not prevent dextran sulfate sodium induced murine intestinal lymphocyte death.
Spagnuolo PA; Hoffman-Goetz L
Exp Biol Med (Maywood); 2008 Sep; 233(9):1099-108. PubMed ID: 18535168
[TBL] [Abstract][Full Text] [Related]
36. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
[TBL] [Abstract][Full Text] [Related]
37. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
38. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory effect of yoghurt in an experimental inflammatory bowel disease in mouse.
Gobbato N; Rachid M; Perdigón G
J Dairy Res; 2008 Nov; 75(4):497-504. PubMed ID: 19032800
[TBL] [Abstract][Full Text] [Related]
40. rHuKGF ameliorates symptoms in DSS and CD4(+)CD45RB(Hi) T cell transfer mouse models of inflammatory bowel disease.
Byrne FR; Farrell CL; Aranda R; Rex KL; Scully S; Brown HL; Flores SA; Gu LH; Danilenko DM; Lacey DL; Ziegler TR; Senaldi G
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G690-701. PubMed ID: 11897629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
